Skip to Main Content

Paper Details

Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.
Diabetes Care
8
2022
Author NameAffiliation
Elisabetta PatornoDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2